ACH
LFCR icon

ArrowMark Colorado Holdings’s Lifecore Biomedical LFCR Stock Holding History

ArrowMark Colorado Holdings’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-82,379
Closed -$1.14M – 276
2014
Q4 		$1.14M Buy
82,379
+64,217
+354% +$830K 0.03% 209
2014
Q3 		$222K Buy
18,162
+6,072
+50% +$75.8K 0.01% 281
2014
Q2 		$151K Sell
12,090
-19
-0.2% -$224 ﹤0.01% 321
2014
Q1 		$135K Hold
12,109
– – ﹤0.01% 298
2013
Q4 		$147K Buy
+12,109
New +$145K ﹤0.01% 303

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ArrowMark Colorado Holdings's LFCR Position: Q1 2015 in Review

ArrowMark Colorado Holdings sold out of Lifecore Biomedical (LFCR) in Q1 2015, closing a stake of 82,379 shares — an estimated $1.14M sold.

ArrowMark Colorado Holdings first reported a position in LFCR in Q4 2013 and held it in 5 quarters. The position peaked at $1.14M in Q4 2014. 99 funds tracked by Wall St. Rank hold LFCR as of Q1 2015.

  • ArrowMark Colorado Holdings reported no remaining Lifecore Biomedical position as of Q1 2015 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 82,379 Lifecore Biomedical shares in Q1 2015, an estimated $1.14M.
  • ArrowMark Colorado Holdings first reported a position in Lifecore Biomedical in Q4 2013 and held it in 5 quarters.
  • ArrowMark Colorado Holdings's Lifecore Biomedical position peaked at $1.14M in Q4 2014.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2015.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2015, filed 15 May 2015.